Effect of Pretreatment With Ticagrelor on Residual Thrombus After Percutaneous Coronary Intervention (PCI) in Patients Presenting With Acute Coronary Syndrome in Comparison With Delayed Treatment at the Time of PCI: an Optical Coherence Tomography Study

Trial Profile

Effect of Pretreatment With Ticagrelor on Residual Thrombus After Percutaneous Coronary Intervention (PCI) in Patients Presenting With Acute Coronary Syndrome in Comparison With Delayed Treatment at the Time of PCI: an Optical Coherence Tomography Study

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 09 Jul 2014

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Coronary stent thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 May 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to withdrawn prior to enrolment.
    • 16 Dec 2013 Planned initiation date changed from 1 Nov 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 25 Oct 2013 Planned End Date changed from 1 Feb 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top